Journal
NATURE
Volume 520, Issue 7547, Pages 358-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/nature14403
Keywords
-
Categories
Funding
- Howard Hughes Medical Institute
- NIH
- Cancer Center [5P30CA045508]
- Boehringer Ingelheim Fonds
- NCI Breast SPORE program [P50-CA58223-09A1]
- Breast Cancer Research Foundation
- Triple Negative Breast Cancer Foundation
- Hope Funds For Cancer Research
- Cancer Research UK [21143] Funding Source: researchfish
- Div Of Biological Infrastructure
- Direct For Biological Sciences [1156643] Funding Source: National Science Foundation
Ask authors/readers for more resources
Cancer metastasis requires that primary tumour cells evolve the capacity to intravasate into the lymphatic system or vasculature, and extravasate into and colonize secondary sites(1). Others have demonstrated that individual cells within complex populations show heterogeneity in their capacity to form secondary lesions(2-5). Here we develop a polyclonal mouse model of breast tumour heterogeneity, and show that distinct clones within a mixed population display specialization, for example, dominating the primary tumour, contributing to metastatic populations, or showing tropism for entering the lymphatic or vasculature systems. We correlate these stable properties to distinct gene expression profiles. Those clones that efficiently enter the vasculature express two secreted proteins, Serpine2 and Slpi, which were necessary and sufficient to program these cells for vascular mimicry. Our data indicate that these proteins not only drive the formation of extravascular networks but also ensure their perfusion by acting as anticoagulants. We propose that vascular mimicry drives the ability of some breast tumour cells to contribute to distant metastases while simultaneously satisfying a critical need of the primary tumour to be fed by the vasculature. Enforced expression of SERPINE2 and SLPI in human breast cancer cell lines also programmed them for vascular mimicry, and SERPINE2 and SLPI were overexpressed preferentially in human patients that had lung-metastatic relapse. Thus, these two secreted proteins, and the phenotype they promote, may be broadly relevant as drivers of metastatic progression in human cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available